Preserved Versus Preservative-Free Latanoprost for the Treatment of Glaucoma and Ocular Hypertension: A Post Hoc Pooled Analysis

被引:0
|
作者
Paul Harasymowycz
Cindy Hutnik
Jean-François Rouland
Francisco J. Muñoz Negrete
Mario A. Economou
Philippe Denis
Christophe Baudouin
机构
[1] University of Montreal,Ivey Eye Institute
[2] Bellevue Ophthalmology Clinics and Montreal Glaucoma Institute,Ophthalmology Department
[3] Western University,Department of Ophthalmology
[4] University of Lille,undefined
[5] Hospital Ramón y Cajal,undefined
[6] Universidad Alcalá,undefined
[7] Ophthalmology,undefined
[8] Queen Sofia Hospital,undefined
[9] Praktikertjänst,undefined
[10] HEH,undefined
[11] Hospices Civils de Lyon,undefined
[12] Quinze-Vingts National Ophthalmology Hospital,undefined
来源
Advances in Therapy | 2021年 / 38卷
关键词
Open-angle glaucoma; Ocular hypertension; Hyperemia; Ocular surface disease; Intraocular pressure; Latanoprost; Preservative-free; Monoprost; Patient satisfaction;
D O I
暂无
中图分类号
学科分类号
摘要
Preservatives in eye drops for glaucoma can cause side effects such as stinging and eye redness. These side effects can cause some patients to reduce the frequency of the drops as prescribed or stop using the drops. One of the most common drops for glaucoma is latanoprost. This study evaluated whether a preservative-free latanoprost (PFL) is as effective as preservative-containing latanoprost (PCL) for reducing eye pressure and whether PFL is better tolerated in patients with glaucoma. The results of the study indicated that PFL was as effective as PCL for reducing eye pressure. The results also indicated PFL was much better at reducing the side effects related to PCL. For example PFL reduces eye redness up to twofold compared to PCL. By reducing the side effects associated with PCL patients may continue to take their glaucoma drops as directed and thereby reduce the risk of vision loss from glaucoma.
引用
收藏
页码:3019 / 3031
页数:12
相关论文
共 50 条
  • [21] Comparative efficacy and safety of preserved versus preservative-free beta-blockers in patients with glaucoma or ocular hypertension: a systematic review
    Skov, Anne Guldhammer
    Rives, Amalie Santaolalla
    Freiberg, Josefine
    Virgili, Gianni
    Azuara-Blanco, Augusto
    Kolko, Miriam
    ACTA OPHTHALMOLOGICA, 2022, 100 (03) : 253 - 261
  • [22] Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
    Ermis, Sitki Samet
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 673 - 678
  • [23] Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial
    Dai Woo Kim
    Jonghoon Shin
    Chang Kyu Lee
    Myungjin Kim
    Sohyeon Lee
    Seungsoo Rho
    Scientific Reports, 11
  • [24] Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial
    Kim, Dai Woo
    Shin, Jonghoon
    Lee, Chang Kyu
    Kim, Myungjin
    Lee, Sohyeon
    Rho, Seungsoo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [25] Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis
    Hamacher, Thomas
    Airaksinen, Juhani
    Saarela, Ville
    Liinamaa, M. Johanna
    Richter, Ulrich
    Ropo, Auli
    ACTA OPHTHALMOLOGICA, 2008, 86 : 14 - 19
  • [26] Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial
    Bacharach, Jason
    Ahmed, Iqbal Ike K.
    Sharpe, Elizabeth
    Korenfeld, Michael S.
    Zhang, Steven
    Baudouin, Christophe
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 2575 - 2588
  • [27] Retinal Ganglion Cell Function and Perfusion following Intraocular Pressure Reduction with Preservative-Free Latanoprost in Patients with Glaucoma and Ocular Hypertension
    Daka, Qendrese
    Sustar Habjan, Maja
    Meglic, Andrej
    Perovsek, Darko
    Atanasovska Velkovska, Makedonka
    Cvenkel, Barbara
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [28] Impact of preserved and preservative-free latanoprost on the survival of conjunctival goblet cells
    Mouhammad, Z. Ahmad
    Brindstrup, C. Taul
    Begun, X.
    Nagymihaly, R.
    Heegaard, S.
    Petrovski, G.
    Kolko, M.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 3 - 3
  • [29] Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized,multicenter, controlled phase Ⅲ trial
    Joon Mo Kim
    Kyung Rim Sung
    Ji Woong Lee
    Haksu Kyung
    Seungsoo Rho
    Chan Yun Kim
    International Journal of Ophthalmology, 2021, 14 (10) : 1539 - 1547
  • [30] BAK to the Future? Preserved and Preservative-Free Topical Glaucoma Medications
    Saeedi, Osamah
    Chen, Victoria
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2022, 48 (04): : 139 - 140